Long COVID symptoms and sleep problems: a population‐based study
Authors:
- Anna LetíciaALAnna Letícia
- Rosália Garcia NevesRNRosália Garcia Neves
- Yohana Pereira VieiraYVYohana Pereira Vieira
- Tatiane Nogueira GonzalesTGTatiane Nogueira Gonzales
- Melissa MarochiMMMelissa Marochi
- Rodrigo Zopellaro ReisRRRodrigo Zopellaro Reis
- Karla Pereira MachadoKMKarla Pereira Machado
- Suele Manjourany Silva DuroSDSuele Manjourany Silva Duro
- Mirelle de Oliveira SaesMSMirelle de Oliveira Saes
- 5 September 2024
- journal article
- research article
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (2) , e14327
Abstract
Summary: To investigate the association between symptoms of long‐term effects of coronavirus disease 2019 (long COVID) and sleep problems in a sample population from southern Brazil. This cross‐sectional study used data from the SULcovid‐19 survey, developed in the municipality of Rio Grande, RS, Brazil. The outcome, long COVID, was investigated through the presence of 18 symptoms, and the exposure variable was sleep problems. Poisson regression with robust adjustment for variance was used to estimate crude and adjusted prevalence ratios for the outcome–exposure relationship. Odds ratio was calculated through multinomial regression of the relationship between the number of symptoms of long COVID and sleep problems. Analyses were adjusted for sex, age, marital status, income, body mass index, smoking status, comorbidities, and hospital admission. A total of 2919 adults and older adults were interviewed. The prevalence of long COVID was 48.3% (95% confidence interval [CI] 46.5–50.1%) and sleep problems were reported by 41.2% of the sample (95% CI 39.4–43.0%). Individuals with sleep problems were more likely to exhibit altered sensitivity (prevalence ratio [PR] 3.27; 95% CI 1.96–5.45), nasal congestion (PR 2.75; 95% CI 1.53–4.94), musculoskeletal symptoms (PR 1.75; 95% CI 1.48–2.06), respiratory issues (PR 1.58; 95% CI 1.24–2.01), and one or more symptom of long COVID (PR 1.27; 95% CI 1.15–1.39). Approximately one‐half of the population analysed had long COVID, and four of 10 reported experiencing sleep problems. In addition, the sample tended to have experienced a greater number of symptoms compared with those who reported to sleep well.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (21/2551‐0000107‐0)
This publication has 15 references indexed in Scilit:
- Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic reviewFamily Practice, 2021
- Symptoms, complications and management of long COVID: a reviewJournal of the Royal Society of Medicine, 2021
- Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatmentsInfectious Diseases, 2021
- The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysisAnnals of the New York Academy of Sciences, 2020
- The Sleep-Immune Crosstalk in Health and DiseasePhysiological Reviews, 2019
- Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐AnalysisJournal of the American Heart Association, 2018
- Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regressionSleep Medicine, 2017
- Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep DeprivationBiological Psychiatry, 2016
- Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary diseaseSleep Medicine, 2011